About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Paracetamol No Better Than Dummy Drugs in Low-Back Pain

by Bidita Debnath on July 24, 2014 at 11:30 PM
Font : A-A+

 Paracetamol No Better Than Dummy Drugs in Low-Back Pain

The first-choice lower-back pain killer, paracetamol, worked no better than dummy drugs administered in a trial of more than 1,600 people suffering from the condition, researchers said.

In fact, the median recovery time for those on placebo was a day shorter than that for trial subjects given real medicine, they wrote in The Lancet medical journal.

Advertisement

"Our findings suggest that... paracetamol does not affect recovery time compared with placebo in low-back pain, and question the universal endorsement of paracetamol in this patient group," the Australian team concluded.

"Paracetamol also had no effect on pain, disability, function, global symptom change, sleep or quality of life."

Lower-back pain is the leading cause of disability in the world, and paracetamol is "universally" recommended as the treatment of first choice, said a statement carried by The Lancet.
Advertisement

The Paracetamol for Low-Back Pain Study (PACE) divided 1,652 individuals with acute pain from 235 clinics in Sydney, Australia, into three trial groups.

One group received regular paracetamol doses, the other used the drug as needed, and the third was given placebo pills.

Recovery was defined as seven consecutive days of 0 or 1 pain intensity on a 0-10 scale.

"Median time to recovery was 17 days in the regular paracetamol group, 17 days in the as-needed paracetamol group, and 16 days in the placebo group," said the statement.

All patients were given high-quality advise and reassurance, and the findings suggest these may be more important in lower-back pain management than drug therapy, said the authors.

"Our results convey the need to reconsider the universal endorsement of paracetamol in clinical practice guidelines as first-line care for low-back pain."

A potential limitation of the study was that some participants used other treatments.

In a comment also carried by The Lancet, Bart Koes and Wendy Enthoven from the Universal Medical Center in Rotterdam applauded the team "for tackling this research question on a topic that has been without debate and evidence for such a long time."

But they cautioned that guidelines should not be changed on the basis of a single trial.

Source: AFP
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Is COVID-19 Vaccination during Pregnancy Safe?
Sensory Processing Disorder (SPD)
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Drugs Banned in India 

Recommended Reading
New Prediction Model may Improve Patient Survival Following Paracetamol-related Liver Failure
A high mortality rate has been noted in the UK paracetamol toxicity which is the most common cause ....
Paracetamol Overdose Guidelines Costing NHS Millions
Researchers claim that strict guidelines for treating paracetamol overdoses - introduced 18 months ....
Paracetamol Improves Exercise Endurance
Paracetamol was found to have a positive effect on exercise performance and the body's ability to .....
Paracetamol may Increase Heart Failure Risk in Arthritis Sufferers
Paracetamol may raise the risk of heart failure and stroke in arthritis sufferers, warn doctors....
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Drugs Banned in India
Several drugs are either banned or withdrawn after introduction in the market....

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use